Skip to main content
David Bickers, MD, Dermatology, New York, NY

DavidRBickersMD

Dermatology New York, NY

Carl Truman Nelson Professor of Dermatology, College of Physicians & Surgeons, Columbia University Medical Center

Overview of Dr. Bickers

Dr. David Bickers is a dermatologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Virginia School of Medicine and has been in practice 50 years. He is one of 293 doctors at New York-Presbyterian Hospital and one of 293 doctors at New York-Presbyterian Hospital who specialize in Dermatology. He has more than 100 publications and over 500 citings.

Education & Training

  • Rockefeller University Hospital
    Rockefeller University HospitalFellowship, 1974 - 1977
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Dermatology, 1970 - 1973
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsInternship, Transitional Year, 1967 - 1968
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1967
  • Georgetown University
    Georgetown UniversityA.B., Classics, 1959 - 1963

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1971 - Present
  • NY State Medical License
    NY State Medical License 1970 - 2026
  • OH State Medical License
    OH State Medical License 1977 - 2021
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • America's Top Doctors Castle-Connolly Guide, 2008-2014
  • Honorary Member Society for Investigative Dermatology, 2011
  • Who's Who in the World 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Downregulation of STRA6 expression in epidermal keratinocytes leads to hyperproliferation-associated differentiation in both in vitro and in vivo skin models  
    Skazik C, Amann PM, Heise R, Marquardt Y, Czaja K, Kim A, Ruhl R, Kurschat P, Merk HF, Bickers DR, Baron JM, J Invest Dermatol, 1/1/2014
  • Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma pr evention and therapy in patients with basal cell...  
    Tang JY, Chiou AS, Mackay-Wiggan JM, Aszterbaum M, Chanana AM, Lee W, Lindgren JA, Raphael MA, Thompson BJ, Bickers DR, Epstein EH Jr, Cancer Prev Res, 1/1/2014
  • Hair follicle disruption facilitates pathogenesis of UVB-induced cutaneous inflammation and basal cell carcinoma development in Ptch(+/-)mice  
    Xu J, Weng Z, Arumugam A, Tang X, Chaudhary SC, Li C, Christiano AM, Elmets CA, Bickers DR, Athar M, Am J Pathol, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Tang X, Kim AL, Kopelovich L, Bickers DR, Athar M, J Invest Dermatol, 1/1/2004
  • Phorbol-12 myristate 13-acetate (TPA) inhibits the induction of basal cell carcinomas in ptch1+/- Mice.
    Hebert J, Khaimskiy Y, Athar M, Kopelovich L, Bickers D, Epstein E, J Invest Dermatol, 1/1/2004
  • Resveratrol-induced modulation of MEK-ERK signaling and cell cycle regulation in human epidermoid carcinoma A431 cells.
    Kim AL, Zhu H, Zhu Y, Athar M Bickers DR, J Invest Dermatol, 1/1/2004
  • Join now to see all

Other

  • An approach to the patient with photosensitivity. 
    Bickers DR, Mediguide Derm
    1/1/1987
  • Principles of dermatopharmacology. 
    Bickers DR, Upjohn Publication
    1/1/1983
  • Skin: A major environmental interface. 
    Bickers DR, Guide Prof Pharm
    1/1/1978

Press Mentions

  • CUIMC Update - April 12, 2021
    CUIMC Update - April 12, 2021April 12th, 2021

Grant Support

  • Mechanism-Based Abrogation Of Bcc PathogenesisNational Institute Of Environmental Health Sciences2012
  • Columbia University Medical Center Skin Disease Research Center (CUMCSDRC)National Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
  • Biomedical Research Core Center On Skin Stem CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2010
  • Columbia University Skin Disease Research CenterNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
  • Genetic Mechanisms In Skin DiseasesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2010
  • Molecular Pathogenesis Of Uvb-Induced Skin CancerNational Cancer Institute2004–2008
  • Administrative InfrastructureNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2007
  • Basal Cell Carcinoma:Molecular Pathogenesis &PreventionNational Cancer Institute2002–2006
  • Skin Cancer ChemopreventionNational Cancer Institute1999–2002
  • Skin Cancer--Role Of UVB Induced Cell Cycle AlterationsNational Institute Of Environmental Health Sciences1998–2000
  • Skin Disease Research Core CenterNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2000
  • Skin Metabolism Of Drugs And CarcinogensNational Institute Of Environmental Health Sciences1995–1997
  • Skin Metabolism Of Drugs And CarcinogensNational Institute Of Environmental Health Sciences1994
  • Skin Metabolism Of Drugs And CarcinogensNational Institute Of Environmental Health Sciences1985–1994
  • International Symposium On Environmental Skin CancerNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1992
  • Training In Investigative And Molecular DermatologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1991–1992
  • Skin Diseases Research Center Of Northeast OhioNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1988–1992
  • Porphyrin Photosensitivity Of Skin: Mechanistic StudiesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986–1987
  • Porphyrin Photosensitivity Of Skin: Mechanistic StudiesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985